Monz takes over as ceo of Carl Zeiss Meditec
Ludwin Monz has been named as chief executive of Carl Zeiss Meditec.
Monz has been a member of Carl Zeiss Meditec's management board since October 2007 and is responsible for the firm's Ophthalmological Systems division. Prior to this he led the Microsurgery division for six years.
With a doctorate in physics and an MBA, Monz joined the Carl Zeiss Group in 1994 and has worked in medical technology since 2000.
You may also like
Digital
Abolis launches microbial intelligence platform to optimise bioprocess development
The company has launched MINE, a multi-omics platform designed to help pharmaceutical and other industrial R&D teams identify microbial production pathways, prioritise experiments and support fermentation process optimisation and scale-up
Digital
Charles River and Autolomous launch Apollo Orchestrate LES to digitalise biologics QC testing workflow
The autoloMATE-powered platform connects sample submission, laboratory execution and review into a single digital workflow across Charles River's North American and European Biologics Testing Solutions sites — replacing paper-based processes to accelerate client results
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.